CASN Report: Investments in nursing education vitalCutting nursing education budgets at this time will only increase healthcare expenses in the future, association warns. Second-line drug beats standard treatment in new cases of leukemia Patients with severe asthma benefit from omalizumab The monoclonal antibody omalizumab reduces the risk of exacerbations by about 25% over the course of a year among patients with more severe, persistent asthma. How to stop worrying and love artificial sweeteners Many believe that because they are unnatural they must be unsafe, yet research shows they are safe—especially at real-world levels A stimulating experience Infectious disease centre funding renewed Marvelling over ancient guide for medicinal plants New biopsy key in guiding treatment of metastatic cancer Linking records and lab data improves diabetes outcomes: report Begin brain exercises early to slow mental decline First Previous 382 383 384 385 386 Next Last
